Clinical utility of multigene profiling assays in early-stage breast cancer.

Chang, M C; Souter, L H; Kamel-Reid, S; Rutherford, M; Bedard, P; Trudeau, M; Hart, J; Eisen, A

Chang, M C; Souter, L H; Kamel-Reid, S; Rutherford, M; Bedard, P; Trudeau, M; Hart, J; Eisen, A.

Afiliación

Chang MC; Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto.
Souter LH; Juravinski Hospital, Hamilton.
Kamel-Reid S; Department of Oncology, McMaster University, Hamilton.
Rutherford M; Department of Pathology, University Health Network, Toronto.
Bedard P; Department of Molecular Diagnostics, Health Sciences North, Sudbury.
Trudeau M; Princess Margaret Cancer Centre, Toronto.
Hart J; Odette Cancer Centre, Toronto; and.
Eisen A; Cancer Care Ontario, Toronto, ON.

Curr Oncol ; 24(5): e403-e422, 2017 Oct.

Article en En | MEDLINE | ID: mdl-29089811

Palabras clave

EndoPredict; MammaPrint; Oncotype dx; Practice guidelines; Prosigna; breast cancer; multigene profiling assays; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Curr Oncol Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google